A review of troponin assay performance in Wales: Can the same (method-dependent) decision limits be used in different sites?

Annals of Clinical Biochemistry

Volumn 42, Issue 5, 2005, Pages 351-356

  Thomas, M Annette ^a   Singh, G K ^a   Williams, E J ^b   McDowell, I F W ^c   Tovey, J A ^d   Wayte, A M O ^e  

^a CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^b PRINCESS OF WALES HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d NEVILL HALL HOSPITAL   (United Kingdom)

^e YSBYTY GWYNEDD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN;

ACCURACY; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; PROTEIN DETERMINATION; STATISTICAL ANALYSIS; UNITED KINGDOM;

CHEMISTRY, CLINICAL; HUMANS; LABORATORIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TROPONIN; WALES;

EID: 25144473444     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563054890006     Document Type: Conference Paper

References (12)

1. Consensus Document. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: 1502-13
2. Wu AHB, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R. National Academy of Clinical Biochemistry standards of laboratory practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999; 45: 1104-21
3. Panteghini M, Pagani F, Yeo KT, et al. Evaluation of Imprecision for cardiac troponin assays at low-range concentrations - on behalf of the Committee on standardization of markers of cardiac damage of the IFCC. Clin Chem 2004; 50: 327-32
4. Panteghini M. Recommendations on use of biochemical markers in acute coronary syndrome: IFCC proposals. JIFCC 13: 2 www.ifcc.org/ejifcc
5. Cardiac Marker Scheme Guide. WEQAS publication. Available at http://www.weqas.com/dsp_frame.cfm?link=schemes
6. Fox KAA, Birkhead J, Wilcox R, Knight C, Barth JH. British Cardiac Society Working Group on the definition of myocardial infarction. Ann Clin Biochem 2004; 41: 263-71
7. Morrow DA, Cannon CP, Rifai N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction. J Am Med Assoc 2001; 286: 2405-12
8. Venge P, Lagerqvist B, Diderholm E, Lindahl B, Wallentin L. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol 2002; 89: 1035-41
9. Apple FS, Murakami MAM, Quist HH, Pearce LA, Wieczorek S, Wu AHB. Prognostic value of the Ortho Vitros cardiac troponin I assay in patients with symptoms of myocardial ischaemia. Am J Clin Pathol 2003; 120: 114-20
10. Hickman PE, Koerbin G, Tate J. The reporting of cardiac troponin. Clin Biochem Rev 2003; 24: 99-108
11. Koerbin G, Tate JR, Potter JM, Hickman PE. The comparative analytical performance of four troponin I assays at low concentration. Ann Clin Biochem 2005; 42: 19-23
12. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003; 49: 1331-6